🇺🇸 FDA
Patent

US 9308246

Capsule composition for use as immunogen against Campylobacter jejuni

granted A61KA61K2039/6037A61K2039/627

Quick answer

US patent 9308246 (Capsule composition for use as immunogen against Campylobacter jejuni) held by United States of America as represented by the Secretary of the Air Force expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/6037, A61K2039/627, A61K39/105, A61P